Retinal Nonperfusion and Anti-VEGF Therapy in Diabetic Retinopathy: What We Know and What We Don’t Know

Related

• 

  Expert Panel: AI

  Mark S. Humayun, MD, PhD

  Devinder S Chauhan, MD FRCOphth FRANZCO

  Ursula M. Schmidt-Erfurth, MD

  Jennifer I. Lim, MD, FARVO, FASRS

  Royce WS Chen, MD

  Annual Meeting Talks

  2024

• 

  Progressive Quantitative Outer Retinal Optical Coherence Tomography Abnormalities in Early Diabetic Retinopathy Compared with Controls

  Jennifer I. Lim, MD, FARVO, FASRS

  Annual Meeting Talks

  2022

• 

  Classification and Guidelines for Widefield Imaging: Recommendations From the International Widefield Imaging Study Group

  Netan Choudhry, MD, FRCS(C) FASRS

  Updates from the Field

  2019